Investigating the bile acid mediated control of Clostridioides difficile infection
Clostridioides difficile is a spore forming, anaerobic Gram-positive bacterium. If ingested, spores can cause C. difficile associated disease (CDAD), with symptoms ranging from diarrhoea to pseudomembranous colitis. Germination of spores in the gut is both induced and inhibited by primary and second...
| Main Author: | von Emloh, Louise |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2024
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/77465/ |
Similar Items
Development of an oral vaccine against Clostridioides difficile
by: Karyal, Cansu
Published: (2021)
by: Karyal, Cansu
Published: (2021)
Identification and characterisation of novel bacteriocins active against Clostridioides difficile
by: Chapman, Sarah May Olivia
Published: (2020)
by: Chapman, Sarah May Olivia
Published: (2020)
Developing a protein subunit oral vaccine against Clostridioides difficile
by: Wood, Liam
Published: (2023)
by: Wood, Liam
Published: (2023)
A recombinant non-toxigenic Clostridioides difficile spore vaccine directed against toxigenic C. difficile
by: Aston, Carl
Published: (2022)
by: Aston, Carl
Published: (2022)
Transposon mutagenesis in RT 078 Clostridioides difficile
by: te Vrugt, Marcel
Published: (2023)
by: te Vrugt, Marcel
Published: (2023)
Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in bile acid-farnesoid X receptor-fibroblast growth factor pathway
by: Monaghan, Tanya M., et al.
Published: (2018)
by: Monaghan, Tanya M., et al.
Published: (2018)
Spore germination and recurrence of clostridioides difficile infection
by: Finch, Lorna
Published: (2020)
by: Finch, Lorna
Published: (2020)
The antimicrobial and bile acid mediated control of
Clostridium difficile infection
by: Dempster, Andrew William
Published: (2018)
by: Dempster, Andrew William
Published: (2018)
Obtaining a lytic bacteriophage suitable for use in phage therapy against Clostridioides difficile infection
by: Kerr, Sarah
Published: (2023)
by: Kerr, Sarah
Published: (2023)
Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: A Characterization Study
by: Mooranian, Armin, et al.
Published: (2014)
by: Mooranian, Armin, et al.
Published: (2014)
Application of bile acids in drug formulation and delivery
by: Stojancevic, M., et al.
Published: (2014)
by: Stojancevic, M., et al.
Published: (2014)
Potentials and Limitations of Bile Acids in Type 2 Diabetes Mellitus: Applications of Microencapsulation as a Novel Oral Delivery System
by: Negrulj, Rebecca, et al.
Published: (2013)
by: Negrulj, Rebecca, et al.
Published: (2013)
Both, toxin A and toxin B, are important in Clostridium difficile infection
by: Kuehne, Sarah A., et al.
Published: (2011)
by: Kuehne, Sarah A., et al.
Published: (2011)
Data supporting development and validation of liquid chromatography tandem mass spectrometry method for the quantitative determination of bile acids in feces
by: Shafaei, A., et al.
Published: (2021)
by: Shafaei, A., et al.
Published: (2021)
Towards development of a liposome-based vaccine to combat Clostridium difficile infection
by: Palazi, Panayiota
Published: (2021)
by: Palazi, Panayiota
Published: (2021)
Amino acids utilisation by Clostridium difficile strains
by: Ogbu, H.I.
Published: (2016)
by: Ogbu, H.I.
Published: (2016)
Species Classification and Molecular Studies of Bile Salt Hydrolase (BSH) Gene in Bifidobacterium Spp
by: Mustafa, Shuhaimi
Published: (2003)
by: Mustafa, Shuhaimi
Published: (2003)
Understanding certain Clostridium difficile virulence and antibiotic resistance factors and how these relate to patient clinical outcome
by: Kinsmore, Natasha Louise
Published: (2019)
by: Kinsmore, Natasha Louise
Published: (2019)
Exposing hidden putative lipoproteins in Clostridium difficile
by: Griffin, R., et al.
Published: (2017)
by: Griffin, R., et al.
Published: (2017)
Identification and characterisation of tail components modulating host range of Clostridium difficile phages
by: Steczynska, Joanna
Published: (2023)
by: Steczynska, Joanna
Published: (2023)
Extraction and quantitative determination of bile acids in feces
by: Shafaei, A., et al.
Published: (2021)
by: Shafaei, A., et al.
Published: (2021)
Reduction of antimicrobial resistance through antimicrobial stewardship
by: Saxby, Claire F.
Published: (2020)
by: Saxby, Claire F.
Published: (2020)
High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection
by: Monaghan, Tanya M., et al.
Published: (2017)
by: Monaghan, Tanya M., et al.
Published: (2017)
An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer
by: Mooranian, Armin, et al.
Published: (2014)
by: Mooranian, Armin, et al.
Published: (2014)
Profiling humoral immune responses to Clostridium difficile-specific antigens by protein microarray analysis
by: Negm, Ola H., et al.
Published: (2015)
by: Negm, Ola H., et al.
Published: (2015)
Isolation and characterisation of four novel bacteriophages infecting clinically relevant PCR ribotypes of Clostridium difficile
by: Whittle, Michaella
Published: (2018)
by: Whittle, Michaella
Published: (2018)
CdtR-mediated regulation of toxin production in Clostridium difficile
by: Bilverstone, Terry W.
Published: (2019)
by: Bilverstone, Terry W.
Published: (2019)
A protein microarray assay for serological determination of antigen-specific antibody responses following Clostridium difficile infection
by: Negm, Ola H., et al.
Published: (2018)
by: Negm, Ola H., et al.
Published: (2018)
Analysis of the spore germination mechanisms of Clostridium difficile
by: Burns, David Alexander
Published: (2011)
by: Burns, David Alexander
Published: (2011)
Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics
by: Mooranian, Armin, et al.
Published: (2014)
by: Mooranian, Armin, et al.
Published: (2014)
Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration
by: Negm, Ola H., et al.
Published: (2017)
by: Negm, Ola H., et al.
Published: (2017)
Identification and characterisation of potential bacteriocins with biological activity against Clostridium difficile from environmental samples
by: Kim, Sungchan
Published: (2018)
by: Kim, Sungchan
Published: (2018)
Investigation of the effect of insertional mutation in agr and sigB loci in Clostridium difficile R20291
by: Montfort-Gardeazabal, Jorge M.
Published: (2017)
by: Montfort-Gardeazabal, Jorge M.
Published: (2017)
Mucosal cell responses to Clostridium difficile toxins
by: Mullan, Nivette K.
Published: (2011)
by: Mullan, Nivette K.
Published: (2011)
Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats
by: Al-Salami, Hani, et al.
Published: (2009)
by: Al-Salami, Hani, et al.
Published: (2009)
Importance of Toxin A, Toxin B, and CDT in virulence of an epidemic Clostridium difficile strain
by: Kuehne, Sarah A., et al.
Published: (2013)
by: Kuehne, Sarah A., et al.
Published: (2013)
Gene expression, characterization and in silico studies of delta fatty acid desaturases
by: Abd Halim, Nur Farah Anis
Published: (2022)
by: Abd Halim, Nur Farah Anis
Published: (2022)
A genetic assay for gene essentiality in Clostridium
by: Walker, David J.F., et al.
Published: (2016)
by: Walker, David J.F., et al.
Published: (2016)
Interactions between cellulose ethers and a bile salt in the control of lipid digestion of lipid-based systems
by: Torcello-Gómez, Amelia, et al.
Published: (2014)
by: Torcello-Gómez, Amelia, et al.
Published: (2014)
Primase is required for helicase activity and helicase alters the specificity of primase in the enteropathogen Clostridium difficile
by: van Eijk, Erika, et al.
Published: (2016)
by: van Eijk, Erika, et al.
Published: (2016)
Similar Items
-
Development of an oral vaccine against Clostridioides difficile
by: Karyal, Cansu
Published: (2021) -
Identification and characterisation of novel bacteriocins active against Clostridioides difficile
by: Chapman, Sarah May Olivia
Published: (2020) -
Developing a protein subunit oral vaccine against Clostridioides difficile
by: Wood, Liam
Published: (2023) -
A recombinant non-toxigenic Clostridioides difficile spore vaccine directed against toxigenic C. difficile
by: Aston, Carl
Published: (2022) -
Transposon mutagenesis in RT 078 Clostridioides difficile
by: te Vrugt, Marcel
Published: (2023)